Lorazepam and diazepam rapidly relieve catatonic features in major depression

Yi Yung Hung, Tiao Lai Huang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

28 Scopus citations

Abstract

We have proved that a modified strategy (ie, lorazepam intramuscular injection [IMI] or diazepam intravenous drip [IVD] if lorazepam IMI fails) can rapidly relieve catatonic features in patients with schizophrenia. During a period of 3 years, we identified 7 major depressive patients with catatonic features in the emergency unit of a general hospital. The patients were treated with lorazepam IMI (dose, 2 mg/mL•per ampule) once or twice during the first 2 hours. If lorazepam IMI failed, diazepam IVD (dose, 10 mg/2mL•per ampule) in 500 mL normal saline every 8 hours for 1 day would be administered. The total complete remission rate to lorazepam IMI within 2 hours was 6 (85.7%) per 7 patients, and the total complete remission rate to benzodiazepines (lorazepam IMI and diazepam IVD) within 1 day was 7 (100%) of all 7 patients. These results highly suggest that this modified strategy can also rapidly relieve catatonic features in major depression within 1 day and attain a high complete remission rate, even without electroconvulsive therapy.

Original languageEnglish
Pages (from-to)144-147
Number of pages4
JournalClinical Neuropharmacology
Volume29
Issue number3
DOIs
StatePublished - 05 2006

Keywords

  • Catatonia
  • Diazepam
  • Lorazepam
  • Major depressive disorder

Fingerprint

Dive into the research topics of 'Lorazepam and diazepam rapidly relieve catatonic features in major depression'. Together they form a unique fingerprint.

Cite this